Chronic Periodontitis Clinical Trial
Official title:
Effect of Ashwagandha (Withania Somnifera) as an Adjunct to Scaling and Root Planing on Salivary Antioxidant and Serum c Reactive Protein Levels in Chronic Generalized Periodontitis- a Randomized Double Blind Clinico-biochemical Trial
Periodontal disease is an immune-inflammatory disease which consists of connective tissue breakdown, loss of attachment, and alveolar bone loss.In normal physiology, there is an equilibrium maintained between reactive oxygen species (ROS) activity and antioxidant defence capacity. when this equilibrium changes and shifts in favour of ROS, it will result in oxidative stress (OS). Increased levels of acute phase proteins have been associated with gingival inflammation and periodontitis, which reflected the locally stressed environment. it has been well established that in chronic inflammation sites there is over-production of ROS. The human body consists of an array of antioxidant defense mechanisms (non-enzymatic and enzymatic antioxidants) which removes harmful ROS as soon as they are formed and prevent their deleterious effects. Superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase are the enzymatic antioxidants, while the nonenzymatic antioxidants include vitamins E and C, and reduced glutathione. C - reactive protein (CRP) is a plasma protein that reflects a measure of the acute phase response to inflammation and is one of the markers of choice in monitoring this response. Changes in peripheral blood cellular and molecular components can be seen in patients with periodontitis, as periodontitis includes inflammatory changes of the periodontal tissues. Ashwagandha is also known as Indian ginseng and winter cherry. It consists of dried roots of Withania Somnifera (Family: Solanaceae).6 The Sanskrit words ashva meaning horse, and gandha meaning smell together form the name Ashwagandha. Ashwagandha possessed marked anti-inflammatory effect against denaturation of protein in vitro. the effect was plausibly due to the alkaloid and withanolide contents of ashwagandha. It is a multipurpose herb, which acts as adaptogenic, antioxidant, anticancer, anxiolytic, antidepressant, cardio protective, thyroid modulating, immunomodulating, antibacterial, anti-inflammatory, neuroprotective, cognitive enhancing and hematopoietic agent.So, this study is carried out to assess SOD & CRP levels with or without Ashwagandha supplementation as an adjunct to scaling and root planing(SRP) in chronic periodontitis(CP) patients.
Periodontal disease is an immune-inflammatory disease which consists of connective tissue
breakdown, loss of attachment, and alveolar bone loss.1 In normal physiology, there is an
equilibrium maintained between reactive oxygen species (ROS) activity and antioxidant defence
capacity. Thus when this equilibrium changes and shifts in favour of ROS, it will result in
oxidative stress (OS). OS plays a causative role in pathogenesis of periodontal disease.2
Increased levels of acute phase proteins have been associated with gingival inflammation and
periodontitis, which reflected the locally stressed environment.3 The human body consists of
an array of antioxidant defense mechanisms (non-enzymatic and enzymatic antioxidants) which
removes harmful ROS as soon as they are formed and prevent their deleterious effects.
Superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase are the enzymatic
antioxidants, while the nonenzymatic antioxidants include vitamins E and C, and reduced
glutathione.2 C - reactive protein (CRP) is a plasma protein that reflects a measure of the
acute phase response to inflammation and is one of the markers of choice in monitoring this
response. CRP can be used for the prediction and early detection of periodontal disease as it
is a sensitive marker to evaluate the inflammatory status.4 Ayurveda is the traditional
system of medicine practiced in India that can be traced back to 6000 BC .It is a basic
foundation of ancient medical science in India. Ashwagandha is also known as Indian ginseng
and winter cherry. It consists of dried roots of Withania Somnifera (Family: Solanaceae).6
The Sanskrit words ashva meaning horse, and gandha meaning smell together form the name
Ashwagandha. The root has been described as having a strong "horse like" aroma, although some
experts note that the origin of the name suggests that one who ingests it can attain the
strength and vitality of a horse.7 Ashwagandha possessed marked anti-inflammatory effect
against denaturation of protein in vitro. the effect was plausibly due to the alkaloid and
withanolide contents of ashwagandha.6 Ashwagandha root has major bioactive constituents which
are steroidal alkaloids and lactones known as withanolides which have immunomodulatory
effect.8 It is a multipurpose herb, which acts as adaptogenic, antioxidant, anticancer,
anxiolytic, antidepressant, cardio protective, thyroid modulating, immunomodulating,
antibacterial, antifungal, anti-inflammatory, neuroprotective, cognitive enhancing and
hematopoietic agent.7 Also, by taking Ashwagandha regularly one can enhance his memory and
learning skills dramatically.9So, this study is carried out to assess SOD & CRP levels with
or without Ashwagandha supplementation as an adjunct to scaling and root planing(SRP) in
chronic periodontitis(CP) patients.
MATERIALS AND METHODS
The study will be a randomized double-blind clinical and biochemical trial in which 50
subjects with CP in the age group of 30-55 years, reporting to Department of Periodontology,
TKDC and RC, New Pargaon will be equally and randomly divided into Test Group (TG) and
Control Group (CG). The randomization will be done based on consort guidelines 2010 14
TG will be provided with Ashwagandha capsules 500 mg twice daily, after meals with plain
water for 1 month and CG will be provided with placebo. SRP will be done at baseline in TG
and CG. Clinical and biochemical parameters will be recorded at baseline, 1st month (4 weeks)
and 2nd month (8 weeks). Whole saliva sample (unstimulated) will be collected. Recall visits
will be carried out on 4th week and 8th week. Oral hygiene instructions and reinforcement
will be carried out.
Questionnaire will be provided to both the groups for evaluation. All participants will be
explained the need and design of the study and written consent will be obtained from each
individual prior to the commencement of the study.
Special Instructions Given Regarding with Diet to the Patients during Ashwagandha
supplementation period:-
1. No Deep Fry Food should be eaten.
2. No Sour substances.
3. No Pastry Flour (Maida) made foodstuffs.
SAMPLE COLLECTION METHOD-
A ] SALIVA- 2 ml of unstimulated saliva will be collected in a sterile container.
Centrifugation will be done for 10 minutes at 4000 rpm.16 Then the supernatant will be
removed and stored at 2oC till the assay procedure.
Collection of Saliva Sample: Mahvash Navazesh 200817 Unstimulated whole saliva will be
collected for the estimation of SOD.2ml will be collected from each subject between
9.00-10.00a.m.The participants will be requested not to eat or drink anything except water in
the morning before sampling. This will ensure that the variability in salivary flow and
composition be minimum due to diurnal variation. The subject will be asked to rinse the mouth
with distilled water thoroughly to remove any food debris.
B) Serum CRP detection
Samples:
Three ml of venous blood were taken from all patients at baseline, after 4 weeks and 8 weeks.
METHODS OF BIOCHEMICAL ANALYSIS- SOD- Kajridas method C Reactive Protein- hs CRP-
Nephelometry.
STATISTICAL ANALYSIS WILL BE DONE BY USING:
With 95% confidence and 80% power minimum 46 patients from either groups, test as well as
control group, is required to be included in the study. To compensate for potential dropouts,
50 patients will be considered, 25 patients constituting in each group.
Tests will be done are:-
1. ANOVA repeated measures post hoc.
2. Independent T test.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06400069 -
Role of NLRP6 in Chronic Periodontitis
|
||
Completed |
NCT05231096 -
Comparison of the Effect of Gingival Massage of Aloe-vera Gel and Sidr Honey on Chronic Periodontitis
|
N/A | |
Completed |
NCT03203746 -
Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03354338 -
Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy
|
Phase 2 | |
Completed |
NCT02516111 -
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
|
Phase 2/Phase 3 | |
Completed |
NCT02174146 -
Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy
|
N/A | |
Terminated |
NCT02568163 -
Influence of Stress on Non Surgical Periodontal Treatment
|
N/A | |
Completed |
NCT02430519 -
Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects
|
N/A | |
Completed |
NCT01438333 -
Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection
|
N/A | |
Completed |
NCT01233765 -
Analysis of Neutrophil Response in Chronic Periodontitis
|
N/A | |
Completed |
NCT02218515 -
Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft
|
Phase 4 | |
Completed |
NCT02197260 -
Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing
|
Phase 4 | |
Not yet recruiting |
NCT03270280 -
Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis
|
Phase 2 | |
Not yet recruiting |
NCT04026828 -
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods
|
||
Completed |
NCT04643288 -
Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects
|
N/A | |
Completed |
NCT04697199 -
The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis
|
Phase 1 | |
Completed |
NCT03039244 -
Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers
|
N/A | |
Completed |
NCT02518152 -
Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis
|
Phase 2/Phase 3 | |
Completed |
NCT03874390 -
Effects of Ozone Therapy on Clinical Parameters and Inflammatory Cytokines in Chronic Periodontitis Patients
|
N/A | |
Completed |
NCT02851823 -
Combined Use of Er:YAG and Nd:YAG Laser
|
N/A |